.png "Mary-Ann Fitzcharles, MD, FRCPC photo")
McGill University
Montreal-West, QC, Canada
Mary-Ann Fitzcharles has worked as a clinician, teacher and clinical researcher at McGill University, Montreal Canada since 1982. She completed her medical training at University Cape Town, South Africa, and further specialized as a rheumatologist at the London Hospital, Whitechapel, England. Her career interest has been focused towards the clinical context of pain in the rheumatic diseases, beginning with early work in fibromyalgia syndrome. She has served as the Co-Chair of the American College of Rheumatology Pain and Fibromyalgia abstract committee; is a member of American College of Rheumatology committee for updated criteria for fibromyalgia; founder member of the Royal College of Physicians of Canada specialty committee for Pain Medicine; past member of the Royal College of Physicians of Canada examination committee for Pain Medicine and past chair and current member of the Canadian Rheumatology Association (CRA) Therapeutics committee. She is the lead for the 2012 Canadian guidelines for the management of fibromyalgia and is the lead for the CRA position statement on medical cannabis for rheumatic diseases. Recent work has been focused towards pain management in the rheumatic diseases with publications and national and international presentations addressing use of opioids and cannabinoids in rheumatology patients.
Disclosure information not submitted.
Saturday, November 12, 2022
1:00 PM – 3:00 PM Eastern Time
Saturday, November 12, 2022
5:15 PM – 5:25 PM Eastern Time
